ETW Medical Travel 赴美治癌服務中心

03/22/2022

01/19/2022

https://twitter.com/asco/status/1482412271225741316?s=21

“Many studies investigating targeting w trastuzumab combo therapy, such as HERACLES-A, MOUNTAINEER, & DESTINY-CRC01, have had encouraging results & demonstrate the potential of these therapies for patients w . https://t.co/e2NZoyOEgp ”

01/19/2022

https://twitter.com/onclive/status/1482502924655906820?s=21

“Treatment with APVO436 caused cytokine release syndrome in approximately 1 of 5 patients with relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome but was generally well managed with steroids. https://t.co/84b6tKN5uB”

01/19/2022

https://twitter.com/onclive/status/1483469954863222789?s=21

“Hear leading experts discuss how ENHERTU® (fam-trastuzumab deruxtecannxki) may help your patients https://t.co/dqCUF2qQzq. See Important Safety Information & complete Prescribing Information, including Boxed WARNINGS and Medication Guide at https://t.co/NHhFcYb1uh”

01/19/2022

https://twitter.com/e_de_azambuja/status/1483361410553888769?s=21

“The addition of capecitabine to a chemotherapy regimen that contained docetaxel, epirubicin, and cyclophosphamide prolonged the of with https://t.co/egLKGZEg6q”

11/27/2021

Repost: Belzutifan results in strong clinical activity in patients with tumors associated with von Hippel-Lindau disease according to recent findings from a Phase II clinical trial led by our Dr. Eric Jonasch
https://twitter.com/mdandersonnews/status/1463905323903815682?s=21

“Belzutifan results in strong clinical activity in patients with tumors associated with von Hippel-Lindau disease according to recent findings from a Phase II clinical trial led by our Dr. Eric Jonasch: https://t.co/tFBqGZcOBN ”

11/27/2021

https://twitter.com/mdandersonnews/status/1464217883878244361?s=21

“Dr. Sairah Ahmed explains how double-hit lymphoma, a rare and aggressive subtype of diffuse large B-cell lymphoma, is diagnosed and treated: https://t.co/lCinQ1hYLP. ”

11/25/2021

https://twitter.com/mdandersonnews/status/1463734950558064642?s=21

“Commonly used as allergy medication, antihistamines may also help improve patient response to immune checkpoint inhibitors, according to new research from our team: https://t.co/NuVP46oxKV ”

11/24/2021

https://twitter.com/papaemmanuillab/status/1463177194084175881?s=21

“Leveraging the neuroblastoma biobank at we deployed whole genome sequencing approaches to study response to treatment & metastasis in 283 patients. Uncovering the effectors of a lethal pediatric cancer. Work led by https://t.co/43mJLJtvFf”

11/24/2021

https://twitter.com/drchoueiri/status/1463144142083657728?s=21

“Just In: Approves Sirolimus Protein-bound Particles for Locally Advanced Unresectable or Metastatic PEComa, via cc: https://t.co/FZHCgqIFcR”

11/23/2021

https://twitter.com/mayoclinic/status/1462922089380331527?s=21

“ICYMI – Science Saturday: Regenerative technology uncovers new discoveries in liver disease https://t.co/x6DDC5aT30”

11/23/2021

https://twitter.com/mdandersonnews/status/1461185402325319686?s=21

“Combining checkpoint blockade and cryoablation stimulates immune remodeling in advanced kidney cancer, according to a study led by our Dr. Matthew Campbell and Dr. Padmanee Sharma: https://t.co/Lqtd6LdTPq ”

11/23/2021

https://twitter.com/mdandersonnews/status/1462563986579283969?s=21

“When Jacob McCoy's doctors discovered that it would be impossible to remove a benign acoustic neuroma without affecting his hearing or causing facial paralysis, they used a targeted radiation approach, Gamma Knife radiosurgery. https://t.co/3XRqFmpiLT ”

11/06/2021

https://twitter.com/NatureComms/status/1456679705415876614?s=20

“The and colleagues combine spatially resolved transcriptomics and single-cell RNA-seq to study the role of cilia at the tumor microenvironment interface https://t.co/YRHRwVRw3E”

10/23/2021

10/22/2021